Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

medicine

20 posts
ZZürich
Cruise ship passenger with hantavirus being treated in Zurich | National News
Read More

Cruise ship passenger with hantavirus being treated in Zurich | National News

  • 2026-05-12
A former passenger on a cruise ship stricken by a deadly hantavirus outbreak is being treated in a…
ZZürich
Cruise ship passenger with hantavirus being treated in Zurich | National
Read More

Cruise ship passenger with hantavirus being treated in Zurich | National

  • 2026-05-06
A former passenger on a cruise ship stricken by a deadly hantavirus outbreak is being treated in a…
RRoche
HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics
Read More

HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics

  • 2026-04-28
HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics HNL Lab Medicine and Roche Diagnostics mark the formalization…
SSwitzerland
What has Switzerland learned about drug shortages?
Read More

What has Switzerland learned about drug shortages?

  • 2026-04-23
Danish shipping giant Maersk announced on March 1st 2026 that it will reroute all vessels on its Middle…
SSwitzerland
What has Switzerland learned about drug shortages?
Read More

What has Switzerland learned about drug shortages?

  • 2026-04-23
Danish shipping giant Maersk announced on March 1st 2026 that it will reroute all vessels on its Middle…
ZZürich
How ETH Zurich is responding to the global helium shortage – Staffnet
Read More

How ETH Zurich is responding to the global helium shortage – Staffnet

  • 2026-04-15
Helium plays a crucial role in basic research at ETH Zurich. In fields such as physics, chemistry, biology,…
NNovartis
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Read More

Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%

  • 2026-03-29
– Novartis today announced final two-year results from the Phase III APPLAUSE‑IgAN study of Fabhalta® (iptacopan) in IgA…
GGeneva
Patient a minute late has appointment canceled at RRH Geneva | Health
Read More

Patient a minute late has appointment canceled at RRH Geneva | Health

  • 2026-03-21
GENEVA — It is not out of the ordinary for a patient or a doctor to be late…
ZZürich
New treatment for combating iron deficiency more effectively
Read More

New treatment for combating iron deficiency more effectively

  • 2026-03-14
Iron deficiency is globally widespread. Women are particularly affected, with one in five in Europe suffering from iron…
NNovartis
Novartis Inks Up-to-$5.7B Second Collaboration with Monte Rosa
Read More

Novartis Inks Up-to-$5.7B Second Collaboration with Monte Rosa

  • 2026-03-10
Nearly a year after licensing Monte Rosa Therapeutics’ Phase II-bound autoimmune disease candidate MRT-6160, Novartis has agreed to…
RRoche
New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus
Read More

New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus

  • 2026-03-06
Over three quarters of people on Gazyva/Gazyvaro plus standard therapy achieved at least a four-point improvement in SRI-4,…
RRoche
Emcure Pharmaceuticals Partners with Roche for Nephrology and Transplant Medicines in India
Read More

Emcure Pharmaceuticals Partners with Roche for Nephrology and Transplant Medicines in India

  • 2026-03-02
Emcure Pharmaceuticals announced a strategic partnership with Roche on Monday, agreeing to distribute select nephrology and transplant…
Switzerland
www.europesays.com